Chlamydia pneumoniae infection, complement factor H variants and age-related macular degeneration

被引:17
|
作者
Shen, D.
Tuo, J.
Patel, M. [2 ]
Herzlich, A. A.
Ding, X.
Chew, E. Y. [3 ]
Chan, C-C [1 ]
机构
[1] NEI, Immunopathol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA
[2] NIH, Howard Hughes Med Inst, Res Scholars Program, Chevy Chase, MD USA
[3] NEI, Div Epidemiol & Clin Res, NIH, Bethesda, MD 20892 USA
关键词
NEOVASCULAR MEMBRANES; MULTIPLE-SCLEROSIS; POLYMORPHISM; ASSOCIATION; EXPOSURE; RISK; IDENTIFICATION; METAANALYSIS; PROGRESSION; GENE;
D O I
10.1136/bjo.2008.145383
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background/aims: Impaired inhibition of the alternative complement pathway by complement factor H (CFH) is linked to age-related macular degeneration (AMD) based on the strong association between CFH variant and AMD. Chlamydia pneumoniae (C pneumoniae) infection can trigger the alternative pathway, but the evidence for an association between C pneumoniae and AMD is contradictory. This study investigated whether C pneumoniae infection is associated with AMD and whether the presence of C pneumonia modulates AMD risk conferred by CFH variants. Methods: Genomic DNA extracted from peripheral blood of 148 advanced AMD patients and 162 controls was subjected to Taqman and PCR-RFLP for the CFH polymorphism and PCR for the C pneumoniae gene. Genomic DNA was also examined from microdissected macular cells from 59 AMD and 16 age-matched non-AMD archived slides. chi(2) testing was performed for case-control analysis. Results: C pneumoniae infection was associated with increased risk of AMD (OR = 2.17, p < 0.017). A CFH variant was also linked to increased risk of AMD (OR = 1.98, p < 0.0001). However, no relationship was found between risk-conferring CFH variant and C pneumoniae (OR = 1.81, p = 0.08). Conclusion: There is a possible association between AMD and C pneumoniae infection, although CFH may not be directly involved in the pathogenesis of C pneumoniae infection-mediated AMD.
引用
收藏
页码:405 / 408
页数:4
相关论文
共 50 条
  • [41] Complement inhibitors for age-related macular degeneration
    Tzoumas, Nikolaos
    Riding, George
    Williams, Michael A.
    Steel, David H. W.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2023, (06):
  • [42] Complement inhibitors for age-related macular degeneration
    Williams, Michael A.
    Mckay, Gareth J.
    Chakravarthy, Usha
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (01):
  • [43] The complement system and age-related macular degeneration
    Sivaprasad, S.
    Chong, N. V.
    EYE, 2006, 20 (08) : 867 - 872
  • [44] Age-related macular degeneration and the complement system
    Khandhadia, S.
    Cipriani, V.
    Yates, J. R. W.
    Lotery, A. J.
    IMMUNOBIOLOGY, 2012, 217 (02) : 127 - 146
  • [45] Age-related macular degeneration: Complement in action
    Campagne, Menno van Lookeren
    Strauss, Erich C.
    Yaspan, Brian L.
    IMMUNOBIOLOGY, 2016, 221 (06) : 733 - 739
  • [46] The complement system in age-related macular degeneration
    Armento, Angela
    Ueffing, Marius
    Clark, Simon J.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2021, 78 (10) : 4487 - 4505
  • [47] The complement system and age-related macular degeneration
    S Sivaprasad
    N V Chong
    Eye, 2006, 20 : 867 - 872
  • [48] The complement system in age-related macular degeneration
    Angela Armento
    Marius Ueffing
    Simon J. Clark
    Cellular and Molecular Life Sciences, 2021, 78 : 4487 - 4505
  • [49] Serological Association of Chlamydia pneumoniae Infection with Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis
    Chen, Xueyu
    Jhanji, Vishal
    Chen, Chupeng
    Chen, Haoyu
    PLOS ONE, 2014, 9 (07):
  • [50] Chlamydia pneumoniae and age-related macular degeneration:: a role in pathogenesis or merely a chance association?
    Guymer, Robyn
    Robman, Luba
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2007, 35 (01): : 89 - 93